Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 499 (LINC00499) is a long non-coding RNA (lncRNA) located on chromosome 4 in humans[1][3][5][7][11]. It is a non-protein coding transcript and is also referred to as LINC00500 or long intergenic non-protein coding RNA 500[7][9]. LINC00499 is primarily classified as an lncRNA and is not considered a therapeutic drug target (such as a receptor, enzyme, or transporter), but it is under investigation for its role in gene regulatory networks, including potential associations with neurological disorders such as schizophrenia and affective disorders[12]. There is currently no evidence of drug interactions, mechanisms of drug action, or validated use as a clinical biomarker. Most research focuses on its transcriptional and potential disease-association functions rather than direct therapeutic targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 499 (LINC00499).